Family history, metabolic gene polymorphism, diet and risk of colorectal cancer

European Journal of Cancer Prevention

Volumn 8, Issue SUPPL. 1, 1999, Pages

  Little, J ^a   Faivre, J ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Colorectal cancer; Diet gene interaction; Family history

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN; CYTOCHROME P450; GLUTATHIONE TRANSFERASE;

ACETYLATION; CANCER RISK; COLORECTAL CANCER; CONFERENCE PAPER; COOKING; DIET; DIETARY INTAKE; DNA POLYMORPHISM; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; PRIORITY JOURNAL;

EID: 0033497696     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199912001-00010     Document Type: Conference Paper

References (101)

1. Adams PC (1994). Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 45: 146-9.
2. Ames BN (1983). Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 221: 1256-64.
3. Ayesh R, Idle JR, Ritchie JC et al. (1984). Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312: 169-70.
4. Babbs CF (1990). Free radicals and the etiology of colon cancer. Free Rad Biol Med 8: 191-200.
5. Baron JA, Sandler RS, Haile RW et al (1998). Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 90: 57-62.
6. Bell DA, Badawi AF, Lang NP et al (1995a). Polymorphism in the N-Acetyltransferase 1 (NAT1) Polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55: 5226-9.
7. Bell DA, Stephens EA, Castranio T et al (1995b). Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55: 3537-42.
8. Benito E, Stiggelbout A, Bosch FX et al. (1991). Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 49: 161-7.
9. Benito E, Cabeza E, Moreno V et al. (1993). Diet and colorectal adenomas: a case-control study in Majorca. Int J Cancer 55: 213-19.
10. Berrino F, Sant M, Verdecchia A et al (1995). Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publications No. 132; IARC, Lyon.
11. Bingham SA, Pignatelli B, Pollock JRA et al. (1996). Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 17: 515-23.
12. Bird CL, Swendseid ME, Witte JS et al. (1995). Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 4: 709-14.
13. Boutron MC, Faivre J, Quipourt V et al. (1995). Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut 37: 830-4.
14. Boutron MC, Senesse P, Faivre J (1996). Body mass index, physical activity and the adenoma-carcinoma sequence. Gastroenterology 116: A494.
15. Boutron-Ruault MC, Senesse P, Faivre J et al. (1996). Folate and alcohol intakes: related or independent roles in the adenoma-carcinoma sequence? Nutr Cancer 26: 337-46.
16. Burt RW, Bishop DT, Cannon LA et al. (1985). Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 312: 1540-4.
17. Butler WJ, Ryan P, Roberts-Thomson IC (1997). Metabolic genotypes and risk for colorectal cancer increased risk in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Gastroenterology 112: A542.
18. Cannon-Albright LA, Skolnick MH, Bishop DT et al. (1988). Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 319: 533-7.
19. Cerutti PA (1985). Prooxidant states and tumour promotion. Science 227: 375-81.
20. Chen J, Giovannucci E, Kelsy K et al. (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4.
21. Chen J, Stampfer MJ, Hough HL et al. (1998). A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58: 3307-11.
22. Chenevix-Trench G, Young J, Coggan M et al. (1995). Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16: 1655-7.
23. Cotton S, Sharp L, Little J (1996). The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncogenesis 7: 293-342.
24. Daly AK (1995). Molecular basis of polymorphic drug metabolism. J Mol Med 73: 539-53.
25. Davidson NO (1996). Apolipoprotein E polymorphism: another player in the genetics of colon cancer susceptibility? Gastroenterology 110: 2006-9.
26. Deakin M, Elder J, Hendrickse C et al. (1996). Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17: 881-4.
27. Feinberg AP, Vogelstein B (1983). Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-91.
28. Fernandez E, La Vecchia C, D'Avanzo B et al. (1997). Risk factors for colorectal cancer in subjects with family history of the disease. Br J Cancer 75: 1381-4.
29. Ferraroni M, La Vecchia C, D'Avanzo B et al. (1994). Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 70: 1150-5.
30. Freudenheim JL, Graham S, Marshall JR et al. (1990). A case-control study of diet and rectal cancer in Western New York. Am J Epidemiol 131: 612-24.
31. Freudenheim JL, Graham S, Marshall JR et al. (1991). Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20: 368-74.
32. Frosst P, Blom HJ, Milos R et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-3.
33. Fuchs CS, Giovannucci EL, Colditz GA et al. (1994). A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331: 1669-74.
34. Gerhardsson de Verdier M, Hagman U, Peters RK et al. (1991). Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm. Int J Cancer 49: 520-5.
35. Giovannucci E, Stampfer MJ, Colditz GA et al. (1993). Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85: 875-84.
36. Giovannucci E, Rimm EB, Ascherio A et al. (1995). Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87: 265-73.
37. Glynn SA, Albanes D, Pietinen P et al. (1996). Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 5: 487-94.
38. Goelz SE, Vogelstein B, Hamilton SR et al. (1985). Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187-90.
39. Halliwell B, Gutteridge JM (1986). Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246: 501-14.
40. Hein DW (1988). Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948: 37-66.
41. Herbert V (1987). Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr 45: 661-70.
42. Hickman D, Pope J, Patil SD et al (1998). Expression of arylamine W-acetyltransferase in human intestine. Gut 42: 402-9.
43. Hill MJ, Aries VC (1971). Faecal steroid composition and its relationship to cancer of the large bowel. J Pathol 104: 129-39.
44. Hoff G, Moen IE, Trygg K et al. (1986). Epidemiology of polyps in the rectum and sigmoid colon. Evaluation of nutritional factors. Scand J Gastroenterol 21: 199-204.
45. Howe J, Little J, Cassidy J et al. (1998). Colorectal Cancer, Dietary Folate and MTHFR Polymorphism. The 32nd Annual Conference of the International Association of Cancer Registries, Emory University, Atlanta, 55.
46. Hsing AW, McLaughlin JK, Olsen JH et al. (1995). Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 60: 160-2.
47. Hubbard AL, Harrison DJ, Moyes C et al. (1997). N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 41: 229-34.
48. Hunter D (1990). Biochemical indicators of dietary intake. In Nutritional Epidemiology (ed Willett W); Oxford University Press, New York, pp. 143-216.
49. Ilett KF, David, BM, Detchon P et al. (1987). Acetylation phenotype in colorectal carcinoma. Cancer Res 47: 1466-9.
50. Ilett KF, Ingram DM, Carpenter DS et al. (1994). Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem Pharmacol 47: 914-7.
51. Inskip A, Elexperu-Camiruaga J, Buxton N et al. (1995). Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 312: 713-16.
52. Jenkins M, Bigler J, Kampman E et al. (1997). Associations between colon cancer and acetylation (NAT1 and NAT2) genotypes in a large population-based study. Am J Epidemiol 145: S68.
53. Katoh T, Nagata N, Kuroda Y et al. (1996). Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17: 1855-9.
54. Kervinen K, Södervik H, Mäkelä J et al. (1996). Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 110: 1785-90.
55. Kesäniemi YA, Ehnholm C, Miettinen TA (1987). Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578-81.
56. Khoury MJ, Beaty TH, Liang KY (1988). Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127: 674-83.
57. Khoury MJ, Stewart W, Beaty TH (1987). The effect of genetic susceptibility on causal inference in epidemiologic studies. Am J Epidemiol 126: 561-7.
58. Knekt P, Reunanen A, Takkunen H et al. (1994). Body iron stores and risk of cancer. Int J Cancer 56: 379-82.
59. Kotake K, Koyama Y, Nasu J et al. (1995). Relation of family history of cancer and environmental factors to the risk of colorectal cancer: a case-control study. Jpn J Clin Oncol 25: 195-202.
60. Kune GA, Vitetta L (1992). Alcohol consumption and the etiology of colorectal cancer: A review of the scientific evidence from 1957 to 1991. Nutr Cancer 18: 97-111.
61. La Vecchia C, Negri E, Decarli A et al. (1988). A case-control study of diet and colo-rectal cancer in Northern Italy. Int J Cancer 41: 492-8.
62. La Vecchia C, Braga C, Negri E et al. (1997). Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 73: 525-30.
63. Ladero JM, González JF, Benítez J et al. (1991). Acetylator polymorphism in human colorectal carcinoma. Cancer Res 51: 2098-100.
64. Lang NP, Chu DZJ, Hunter CF et al. (1986). Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259-61.
65. Lang NP, Butler MA, Massengill J et al. (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 3: 675-82.
66. Little J, Logan RFA, Hawtin PG et al. (1993). Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer 67: 177-84.
67. Lyon JL, Mahoney AW (1988). Fried foods and the risk of colon cancer. Am J Epidemiol 128: 1000-5.
68. Ma J, Stampfer MJ, Giovannucci E et al. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57: 1098-102.
69. Macquart-Moulin G, Riboli E, Cornée J et al. (1987). Colorectal polyps and diet: a case-control study in Marseilles. Int J Cancer 40: 179-88.
70. Meyer F, White E (1993). Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 138: 225-36.
71. Muscat JE, Wynder EL (1994). The consumption of well-done red meat and the risk of colorectal cancer. Am J Public Health 84: 856-8.
72. Nakajima T, Elovaara E, Anttila S et al. (1995). Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 16:707-11.
73. Nebert DW (1997). Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 60: 265-71.
74. Nelson RL, Davis FG, Sutter E et al. (1994). Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 86: 455-60.
75. Nelson RL, Davis FG, Persky V et al. (1995). Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 76: 875-9.
76. Pariente A, Milan C, Lafon J et al. (1998). Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer: a case-control study. Gastroenterology 115: 7-12.
77. Parkin DM, Pisani P, Ferlay J (1993). Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606.
78. Paspatis GA, Kalafatis E, Oros L et al. (1995). Folate status and adenomatous colonic polyps. A colonoscopically controlled study. Dis Colon Rectum 38: 64-8.
79. Peters RK, Pike MC, Garabrant D et al. (1992). Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 3: 457-73.
80. Probst-Hensch NM, Haile RW, Ingles SA et al. (1995). Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res 55: 2017-20.
81. Probst-Hensch NM, Haile RW, Li DS et al. (1996). Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 17: 2125-9.
82. Roberts-Thomson IC, Ryan P, et al. (1996). Diet, acetylator phenotype and risk of colorectal neoplasia. Lancet 347: 1372-4.
83. Rodriguez JW, Kirlin WG, Ferguson RJ et al. (1993). Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch Toxicol 67: 445-52.
84. Schiffman MH, Felton JS (1990). Re: 'Fried foods and the risk of colon cancer'. Am J Epidemiol 131: 376-9.
85. Sivaraman L, Leatham MP, Yee J et al. (1994). CYPIAI genetic polymorphisms and in situ colorectal cancer. Cancer Res 54: 3692-5.
86. Slattery ML, Caan BJ, Potter JD et al. (1997). Dietary energy sources and colon cancer risk. Am J Epidemiol 145: 199-210.
87. Smith CAD, Smith G, Wolf CR (1994). Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 30A: 1921-35.
88. St John DJB, McDermott FT, Hopper et al. (1993). Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 118: 785-90.
89. Stevens RG, Jones DY, Micozzi MS, et al. (1988). Body iron stores and the risk of cancer. N Engl J Med 319: 1047-52.
90. Tseng M, Murray SC, Kupper LL et al. (1995). Micronutrients and risk of colorectal adenomas. Am J Epidemiol 141: S71.
91. Turesky RJ, Lang NP, Butler MA et al. (1991). Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12: 1839-45.
92. Tuyns AJ, Haelterman M, Kaaks R (1987). Colorectal cancer and the intake of nutrients: oligosaccharides are a risk factor, fats are not. A case-control study in Belgium. Nutr Cancer 10: 181-96.
93. van der Put NMJ, Gabreëls F, Stevens EMB et al. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-51.
94. Vineis P, McMichael A (1996). Interplay between heterocyclic amines in cooked meal and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control 7: 479-86.
95. Ward A, Summers MJ, Sim E (1995). Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49: 1759-67.
96. Weinberg ED (1994). Association of iron with colorectal cancer. Biometals 7: 211-6.
97. Welfare MR, Cooper J, Bassendine MF et al. (1997). Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 18: 1351-4.
98. Wolf CR, Smith CAD, Gough AC et al. (1992). Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 13: 1035-8.
99. World Cancer Research Fund (1997). Food, Nutrition and the Prevention of Cancer: A Global Perspective; World Cancer Research Fund in Association with American Institute for Cancer Research, Menasha.
100. Wurzelmann JI, Silver A, Schreinemachers DM et al. (1996). Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 5: 503-7.
101. Zhong S, Wyllie AH, Barnes D et al. (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-4.